These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 29424306

  • 1. Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- α Inhibitors.
    Campanati A, Molinelli E, Brisigotti V, Offidani A.
    Curr Pharm Biotechnol; 2017; 18(12):945-963. PubMed ID: 29424306
    [Abstract] [Full Text] [Related]

  • 2. Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways.
    Molinelli E, Campanati A, Brisigotti V, Offidani A.
    Curr Pharm Biotechnol; 2017; 18(12):964-978. PubMed ID: 29299984
    [Abstract] [Full Text] [Related]

  • 3. Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts.
    Molinelli E, Campanati A, Ganzetti G, Offidani A.
    Curr Drug Saf; 2016; 11(1):35-43. PubMed ID: 26463248
    [Abstract] [Full Text] [Related]

  • 4. Safety of biologics in psoriasis.
    Kamata M, Tada Y.
    J Dermatol; 2018 Mar; 45(3):279-286. PubMed ID: 29226369
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The status of biologic therapies in the treatment of moderate to severe psoriasis.
    Menter A.
    Cutis; 2009 Oct; 84(4 Suppl):14-24. PubMed ID: 19916298
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.
    Reich K, Burden AD, Eaton JN, Hawkins NS.
    Br J Dermatol; 2012 Jan; 166(1):179-88. PubMed ID: 21910698
    [Abstract] [Full Text] [Related]

  • 13. Biologics in Inflammatory and Immunomediated Arthritis.
    Luchetti MM, Benfaremo D, Gabrielli A.
    Curr Pharm Biotechnol; 2017 Jan; 18(12):989-1007. PubMed ID: 29278210
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A Review of Switching Biologic Agents in the Treatment of Moderate-to-Severe Plaque Psoriasis.
    Hu Y, Chen Z, Gong Y, Shi Y.
    Clin Drug Investig; 2018 Mar; 38(3):191-199. PubMed ID: 29249053
    [Abstract] [Full Text] [Related]

  • 16. New biologics for psoriasis and psoriatic arthritis.
    Rozenblit M, Lebwohl M.
    Dermatol Ther; 2009 Mar; 22(1):56-60. PubMed ID: 19222517
    [Abstract] [Full Text] [Related]

  • 17. Biologic agents in the treatment of psoriasis.
    Guarneri F, Guarneri C, Guarneri B.
    Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):193-217. PubMed ID: 19075983
    [Abstract] [Full Text] [Related]

  • 18. Biologicals in the treatment of psoriasis.
    Boker A, Kimball AB, Rolz-Cruz G.
    Curr Opin Investig Drugs; 2007 Nov; 8(11):939-46. PubMed ID: 17979028
    [Abstract] [Full Text] [Related]

  • 19. Comparative Efficacy and Acceptability of Anti-TNF-Alpha Therapy in Ankylosing Spondylitis: A Mixed-Treatments Comparison.
    Wang Y, Wang H, Jiang J, Zhao D, Liu Y.
    Cell Physiol Biochem; 2016 Nov; 39(5):1679-1694. PubMed ID: 27643888
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.